↓ Skip to main content

American Association for Cancer Research

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC

Overview of attention for article published in Cancer Immunology Research, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
265 Dimensions

Readers on

mendeley
180 Mendeley